Pintarnya | $16,700,000 | (Aug 26, 2025)
Barti | $12,000,000 | (Aug 26, 2025)
Soil Action, Inc. | $5,250,000 | (Aug 26, 2025)
Certified by Founder
Lodge
Therini Bio, Inc.
start up
United States
- South San Francisco, CA
- 27/04/2023
- Series A
- $36,000,000
Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction. Our approach will be generally applicable across a range of inflammatory diseases including peripheral indications. The current therapeutic target is based on novel findings by the Akassoglou lab at Gladstone/UCSF that implicate fibrin as a key driver of neuroinflammation.
- Industry Biotechnology Research
- Website https://www.therinibio.com/
- LinkedIn https://www.linkedin.com/company/therinibio/
Irys | $10,000,000 | (Aug 26, 2025)
Arintra | $21,000,000 | (Aug 26, 2025)
Oway | $4,000,000 | (Aug 26, 2025)
Paragraf | $55,000,000 | (Aug 26, 2025)
Genow | $1,921,342 | (Aug 26, 2025)
Luna Diabetes | $23,600,000 | (Aug 26, 2025)
Dirac, Inc. | $10,700,000 | (Aug 26, 2025)
STARK | $62,000,000 | (Aug 26, 2025)
Incyclix Bio | $11,250,000 | (Aug 26, 2025)